FMR LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 50,970 0.147% |
-1,260,032 (-96.11%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,311,002 5.325% |
299,502 (+29.61%) |
Filing |
| 2021-06-10 11:37 am Sale |
2021-06-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,011,500 4.141% |
-628,778 (-38.33%) |
Filing |
| 2021-02-08 10:25 am Sale |
2021-02-05 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,640,278 9.142% |
-150,513 (-8.40%) |
Filing |